Senior-Level Pharmaceuticals Executives Join Together To Debate Solutions To Fix Pharma's Failing Business Model

Main Category: Pharma Industry / Biotech Industry
Also Included In: Conferences
Article Date: 11 Dec 2008 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

On 2nd March 2009, some 40 senior-level pharmaceutical leaders will gather together in Barcelona Barcelona to discuss the drivers for change in pharma and how they can move and change quickly to sustain growth in these turbulent times.

The event has been born out of the huge pressures pharma is facing right now: pricing pressures; increasing payor power and decreasing prescriber power; and the mounting stress on margins. It couldn't come at a worst time, with shareholders demanding more and more value from pharma thanks to the global economic crisis.

Senior-level leaders from across Europe will meet to thrash out these issues and come to solutions and analyse strategies that will help resolve some of these challenges.

Key on the agenda of The Selling Pharmaceuticals in 2015 Conference, will be how other industries such as the airlines or IT industries have dealt with similar changes. Transformations can be slow in pharma and so seeing how other industries have dealt with comparable challenges will be essential in learning how to fix them in pharma. The event will bring together Jeff Foland, Senior VP Worldwide Sales, United Airlines; Joshua Rossman, formerly Head of Value Sales Team, Cisco Systems, and Director of Enterprise and Partnership, Microsoft and Charles Bellaiche, Regional SAM Director, Hewlett-Packard to find out how what strategies they have used to combat commoditisation and a low value commercial interaction.

Joining them will be key figures from big to medium size pharma in Europe to discuss and debate how this can be applied in pharma - and also find out what has and hasn't worked in the past. Amongst others, Belén Garijo, Senior Vice President Pharmaceutical Operations Europe and Canada, sanofiaventis; Otto Schwarz, Senior Vice President Commercial, Actelion; Marc de Garidel, Head of Operations Southern Europe, Amgen and Alexandre Moreau, Global Franchise Director, sanofiaventis will speak about what they have done and are planning on doing to move their companies from selling products at a price to selling real value and what the implementation challenges are in doing this.

This event has already caused quite a lot of interest in the industry as it is the only event exclusively for senior-level pharmaceutical executives that discusses these key industry issues. Everyone at the event, shares a vision of how they can increase the value of their products and with the help of ZS Associates, delegates and speakers will be taken through a series of presentations and discussions to help them achieve their goals.

About Selling Pharmaceuticals in 2015, 2nd March, 2009, Hotel Rey Juan Carlos

This event has been produced and organised by eyeforpharma, in partnership with ZS Associates. The event aims to bring together senior-level executives from pharma to discuss and debate how they can create mutual value with their customers for sustainable growth. To find out more about the event, visit http://www.eyeforpharma.com/pharma2015.

http://www.eyeforpharma.com